Benjamin L. Ebert, MD, PhD; Peter Libby, MD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-0737.
Corresponding Author: Peter Libby, MD, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB-741-G, Boston, MA 02115; e-mail, plibby@bwh.harvard.edu.
Current Author Addresses: Dr. Ebert: Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215.
Dr. Libby: Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB-741-G, Boston, MA 02115.
Author Contributions: Conception and design: B.L. Ebert, P. Libby.
Analysis and interpretation of the data: B.L. Ebert, P. Libby.
Drafting of the article: B.L. Ebert, P. Libby.
Final approval of the article: B.L. Ebert, P. Libby.
Administrative, technical, or logistic support: P. Libby.
Collection and assembly of data: B.L. Ebert, P. Libby.
Ebert BL, Libby P. Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers. Ann Intern Med. 2018;169:116–117. [Epub ahead of print 29 May 2018]. doi: https://doi.org/10.7326/M18-0737
Download citation file:
© 2019
Published: Ann Intern Med. 2018;169(2):116-117.
DOI: 10.7326/M18-0737
Published at www.annals.org on 29 May 2018
Cardiology, Hematology/Oncology.
Results provided by: